The Cystic Fibrosis Center at Women and Children’s
Hospital of Buffalo, a UB-affiliated teaching hospital, is the
first U.S. site to begin recruiting patients for a study of a
promising investigational treatment for cystic fibrosis.
A group of young entrepreneurs led by Krishnan Chakravarthy, an
MD/PhD candidate in the school’s Medical
Scientist Training Program, has launched NanoAxis, a new research and
development company headquartered in Getzville, New York.